Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -28.57% |
| Q3 2025 | 22.22% |
| Q2 2025 | -3.85% |
| Q1 2025 | 21.21% |
| Q4 2024 | -3.13% |
| Q3 2024 | 8.57% |
| Q2 2024 | -2.94% |
| Q1 2024 | 37.04% |
| Q4 2023 | -38.46% |
| Q3 2023 | -21.88% |
| Q2 2023 | 13.51% |
| Q1 2023 | 7.50% |
| Q4 2022 | 16.67% |
| Q3 2022 | -14.29% |
| Q2 2022 | 4.55% |
| Q1 2022 | 22.81% |
| Q4 2021 | 29.63% |
| Q3 2021 | -35.00% |
| Q2 2021 | -57.89% |
| Q1 2021 | -40.74% |
| Q4 2020 | 50.00% |
| Q3 2020 | 42.55% |
| Q2 2020 | -261.54% |
| Q1 2020 | 3.70% |
| Q4 2019 | 63.51% |
| Q3 2019 | -184.62% |
| Q2 2019 | -18.18% |
| Q1 2019 | 91.85% |
| Q4 2018 | -51.69% |
| Q3 2018 | 81.38% |
| Q2 2018 | -103.84% |
| Q1 2018 | 64.33% |
| Q4 2017 | 77.24% |
| Q3 2017 | -658.27% |
| Q2 2017 | 20.04% |
| Q1 2017 | -102.81% |
| Q4 2016 | 1694.23% |
| Q3 2016 | -184.00% |
| Q2 2016 | -31.12% |
| Q1 2016 | 0.87% |